Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
T.R.H.: Consulting/advisory board for Ipsen, TerSera, ScioScientific, Curium, Advanced Accelerator Applications (a Novartis company), Terumo, ITM Isotopen Technologien Muenchen, and Crinetics, as well as research support from Thermo Fisher Scientific, Advanced Accelerator Applications (a Novartis company), Basilea, Turnstone Biologics, and Agios. The remaining authors have no relevant financial disclosures and declare no conflicts of interest. Financial support was provided internally by the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery and the Mayo Clinic Department of Surgery.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Gudmundsdottir, H., Habermann, E.B., Vierkant, R.A. et al. ASO Visual Abstract: Survival and Symptomatic Relief After Cytoreductive Hepatectomy for Neuroendocrine Tumor Liver Metastases—Long-Term Follow-Up of Over 500 Patients. Ann Surg Oncol 30, 4854–4855 (2023). https://doi.org/10.1245/s10434-023-13424-4
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-023-13424-4